" TDB-DST Supports Helix Cell Therapeutics under Indo-Singapore Collaboration for Advanced CAR-T Cell Therapy against Multiple Myeloma "

• Technology Development Board (TDB), under DST, has signed an agreement with Helix Cell Therapeutics Pvt Ltd, Hyderabad, for a dual-targeting CAR-T cell therapy project against Multiple Myeloma, executed jointly with Biocell Innovations, Singapore.
• Marks operationalisation of the Indo-Singapore collaborative framework in advanced biotech and cell therapy — UPSC-relevant for Sci-Tech (GS-III) and bilateral relations (GS-II).